Spis treści:
Spis załączników:
SFA buyback 11122023 espi.doc (REPORT)
reklama
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
SFA buyback 11122023 espi.doc (REPORT)
przewiń, aby zobaczyć całą tabelę
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 211 | / | 2023 | ||||||||
| Date of issue: | 2023-12-08 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification for buy-back treasury shares | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria, December 8, 2023 - Pursuant to the requirements of Art. 100t of the Law on Public Offering of Securities, "Sopharma" AD (SFA: BSE AD, SPH: Warsaw Stock Exchange) announces that on the basis of Art. 187b of the Commercial Law and Art. 111, para. 5 and para. 6 of the Law on Public Offering of Securities and in connection with the decision of the General Meeting of Shareholders of the company, held on 4 August 2023, and the decision of the Board of Directors of the company from 8 December 2023, "Sopharma" AD notifies that the company intends to buy back treasury shares within the limit according to Art. 111, para. 5 of the Law on Public Offering of Securities, as follows: - Number of shares subject to redemption – 150,000 (one hundred and fifty thousand) shares; - Buy-back price – BGN 6.10 for one share of the company's capital; - Purchase date: 11 December 2023; - Licensed investment intermediary to whom the purchase order was given – “First Financial Brokerage House” AD |
|||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA buyback 11122023 espi.docSFA_buyback_11122023_espi.doc | Notification for buy-back treasury shares | ||||||||||
przewiń, aby zobaczyć całą tabelę
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
przewiń, aby zobaczyć całą tabelę
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2023-12-08 | Ognian Donev | Executive director | |||